ArticleFrontiers in bioengineering and biotechnology2026
Preparation and experimental evaluation of degradable esophageal stents based on novel polylactic acid materials.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal stricture is a common esophageal disorder in both adults and children. The current standard clinical treatment is endoscopic dilation, which suffers from high recurrence rate and the need for repeated dilation. Although metallic esophageal stents can provide long-term support, they tend to cause complications such as migration, perforation, and bleeding, and require a second surgery for removal. Biodegradable stents are regarded as an ideal alternative because they can maintain esophageal patency and degrade spontaneously. To overcome the limitations of existing stents, this study used L-lactide and ε-caprolactone as main raw materials to prepare crosslinked polymers via ring-opening copolymerization and crosslinking reaction, and incorporated a contrast agent to construct a composite material with both imaging function and biodegradable properties. The material structure was characterized by Fourier-transform infrared spectroscopy, proton nuclear magnetic resonance spectroscopy, and gel permeation chromatography. Furthermore, an anti-migration stent structure was designed and fabricated into a solid stent by compression molding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.